CenterPoint Energy, Inc. logo CNP - CenterPoint Energy, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 13
HOLD 17
SELL 1
STRONG
SELL
0
| PRICE TARGET: $44.00 DETAILS
HIGH: $49.00
LOW: $37.00
MEDIAN: $44.00
CONSENSUS: $44.00
UPSIDE: 2.73%

Stock News

CenterPoint Energy conducts full-scale emergency exercise in preparation for 2026 hurricane season

CenterPoint Energy conducts full-scale emergency exercise in preparation for 2026 hurricane season

Emergency exercise, building on CenterPoint's year-round emergency preparedness activities and drills, simulated a response to a major hurricane to strengthen future preparedness, coordination with local emergency agencies and first responders, as well as public and customer communications HOUSTON, May 14, 2026 /PRNewswire/ -- Today, as part of an ongoing effort to strengthen its overall emergency preparedness and response efforts, CenterPoint Energy conducted its annual full-scale emergency response exercise in preparation for the upcoming hurricane season. The emergency exercise, held at CenterPoint's Emergency Operations Center, simulated a Category 3 hurricane impacting the Greater Houston area and included more than 400 members of CenterPoint teams – from Electric and Gas Operations, Emergency Planning & Response, Customer, Communications and others – executing the company's emergency response plan.

May 14, 2026 02:02 PM prnewswire.com
New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years

New 2-Year Data from Pivotal ApproaCH Trial of TransCon® CNP (Navepegritide) Show Pronounced Gains in Growth Outcomes in Children with Achondroplasia Aged ≥5 Years

COPENHAGEN, Denmark, May 06, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from a subgroup analysis showing that children with achondroplasia ≥5 years of age at enrollment treated with once-weekly TransCon CNP (navepegritide) in its pivotal ApproaCH Trial demonstrated significantly greater annualized growth velocity (AGV) compared to placebo at Week 52, and sustained these growth improvements through up to two years of treatment. The safety profile for this subgroup through up to two years of treatment was similar to the overall population, with a low rate of injection site reactions (ISRs, all mild), no symptomatic hypotension, and no acceleration of bone age. The data follow previously reported Week 104 results showing consistent improvements in growth and body proportionality in the overall population, and expand on data recently presented by M. Jennifer Abuzzahab, M.D. during PES 2026, the annual meeting of the Pediatric Endocrine Society.

May 06, 2026 12:01 PM globenewswire.com
CenterPoint Energy (NYSE:CNP) versus Power Assets (OTCMKTS:HGKGY) Critical Survey

CenterPoint Energy (NYSE:CNP) versus Power Assets (OTCMKTS:HGKGY) Critical Survey

CenterPoint Energy (NYSE: CNP - Get Free Report) and Power Assets (OTCMKTS:HGKGY - Get Free Report) are both large-cap utilities companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership. Valuation and Earnings This table compares CenterPoint

Apr 26, 2026 10:22 PM defenseworld.net
CenterPoint Energy reports strong Q1 2026 results; reiterates full-year 2026 guidance; provides an update on Houston Electric load growth

CenterPoint Energy reports strong Q1 2026 results; reiterates full-year 2026 guidance; provides an update on Houston Electric load growth

HOUSTON--(BUSINESS WIRE)--CenterPoint Energy, Inc. (NYSE: CNP), or “CenterPoint,” today reported net income of $316 million, or $0.48 per diluted share, on a GAAP basis for the first quarter of 2026, compared to $0.45 per diluted share in the comparable period of 2025. Non-GAAP EPS for the first quarter of 2026 was $0.56, compared to $0.53 per diluted share in the comparable period of 2025. These strong first-quarter results were primarily driven by growth and regulatory recovery, which contrib.

Apr 23, 2026 02:24 AM businesswire.com
CenterPoint Energy appoints Michael A. "Casey" Herman to Board of Directors

CenterPoint Energy appoints Michael A. "Casey" Herman to Board of Directors

New Director brings deep expertise in audit, governance, strategic planning and long-term financing as well as decades of experience serving the utility industry to the Board HOUSTON, April 16, 2026 /PRNewswire/ -- As part of the ongoing refreshment process of its Board of Directors, CenterPoint Energy (NYSE: CNP) today announced that its shareholders elected a new Director, Michael A. ("Casey") Herman to its Board, effective April 16, 2026.

Apr 16, 2026 02:15 PM prnewswire.com
CenterPoint Energy Declares Regular Common Stock Dividend of $0.2300

CenterPoint Energy Declares Regular Common Stock Dividend of $0.2300

HOUSTON, April 16, 2026 /PRNewswire/ -- CenterPoint Energy, Inc.'s (NYSE: CNP) Board of Directors today declared a regular quarterly cash dividend of $0.2300 per share on the issued and outstanding shares of Common Stock payable on June 11, 2026, to shareholders of record at the close of business on May 21, 2026. About CenterPoint Energy, Inc. CenterPoint Energy, Inc. (NYSE: CNP) is a multi-state electric and natural gas delivery company serving approximately 7 million metered customers across Indiana, Minnesota, Ohio, and Texas.

Apr 16, 2026 02:10 PM prnewswire.com
Massachusetts Financial Services Co. MA Sells 201,806 Shares of CenterPoint Energy, Inc. $CNP

Massachusetts Financial Services Co. MA Sells 201,806 Shares of CenterPoint Energy, Inc. $CNP

Massachusetts Financial Services Co. MA reduced its stake in CenterPoint Energy, Inc. (NYSE: CNP) by 3.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,301,044 shares of the utilities provider's stock after selling 201,806 shares during the period. Massachusetts

Apr 13, 2026 01:28 AM defenseworld.net

Price Targets